GB2430621A — Benzopyranone derivatives as antiviral agents
Assigned to Istituto di Ricerche di Biologia Molecolare P Angeletti SpA · Expires 2007-04-04 · 19y expired
What this patent protects
Use of a compound of formula (I): <EMI ID=1.1 HE=35 WI=92 LX=698 LY=711 TI=CF> <PC>wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, and R<7> are defined herein, and pharmaceutically acceptable salts thereof, in the manufacture of a…
USPTO Abstract
Use of a compound of formula (I): <EMI ID=1.1 HE=35 WI=92 LX=698 LY=711 TI=CF> <PC>wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, and R<7> are defined herein, and pharmaceutically acceptable salts thereof, in the manufacture of a medicament for the treatment or prevention of infection by hepatitis C virus. A pharmaceutical composition comprising compounds of formula (I) also forms part of the current specification.
Drugs covered by this patent
- Zepatier (ELBASVIR) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.